Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Clin Genitourin Cancer. 2022 Feb 9;20(4):e330–e338. doi: 10.1016/j.clgc.2022.02.001

Table 2.

Univariate and multivariable analysis for overall survival

Univariate Analysis of
OS
Multivariable Analysis of OS
Full Model Reduced Model
Characteristic HR (95% CI for
HR)
p-
value
OR (95% Cl
for OR)
p-
value
OR (95% CI for
OR)
p-
value
Age ≥50 (X-tile) 1.42 (9.95-2.12) 0.091
Age ≥60 (median) 1.1 (0.85-2.12) 0.469
Age ≥62 (mean) 1.11 (0.85-1.44) 0.44
Hgb
 Below normal 1 .
 Normal 0.69 (0.5-0.94) 0.018 0.8 (0.58-1.11) 0.175
Corrected Ca++
 Normal 1 .
 Above normal 1.13 (0.75-1.7) 0.555
LDH
 Normal 1 .
 Above normal 1.31 (0.94-1.83) 0.114
Sex (male vs. female) 0.92 (0.7-1.22) 0.572
Race
 Non-Hispanic white 1 .
 Hispanic 0.94 (0.68-1.32) 0.737
 Black 1.28 (0.65-2.52) 0.473
 Asian 2.55 (0.81-8.06) 0.11
cT stage (T3c vs. T3b) 1.59 (1.11-2.28) 0.012 1.81 (1.18-2.79) 0.007 1.83 (1.21-2.76) 0.004
cN1 stage 3.08 (2.2-4.31) <0.001 2.61 (1.79-3.8) <0.001 2.65 (1.83-3.84) <0.001
cM1 stage 2.51 (1.91-3.3) <0.001 2.67 (1.96-3.65) <0.001 2.66 (1.96-3.61) <0.001
Pre-surgical embolization Side 0.9 (0.65-1.26) 0.55
 Left 1 .
 Right 1.23 (0.92-1.63) 0.164
Hypertension 0.75 (0.58-0.98) 0.033 0.98 (0.72-1.33)
Diabetes mellitus 1.09 (0.79-1.51) 0.599
Coronary artery disease 1.26 (0.83-.193) 0.28
Peripheral vascular disease 1.16 (0.29-4.66) 0.838
Microhematuria 0.89 (0.48-1.64) 0.701
Gross hematuria 0.89 (0.68-1.17) 0.405
Flank pain 0.98 (0.73-1.31) 0.868
Weight loss >10 lbs 1.22 (0.92-1.63) 0.169
Malaise weakness fatigue 1.12 (0.84-1.5) 0.427
New-onset congestive heart failure 1.04 (0.56-1.9) 0.911